Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease
Clinical trial NCT03899324 · UNKNOWN
Trial details
- NCT number
- NCT03899324
- Sponsor
- B&A Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2020-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.